Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome.

[1]  A. Ayhan,et al.  Serous surface papillary carcinoma. , 2020, European journal of gynaecological oncology.

[2]  Dongyu Jia,et al.  Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation. , 2015, Gynecologic oncology.

[3]  H. Kitchener,et al.  Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial , 2015, The Lancet.

[4]  Yulei N. Wang,et al.  Upregulation of Periostin and Reactive Stroma Is Associated with Primary Chemoresistance and Predicts Clinical Outcomes in Epithelial Ovarian Cancer , 2015, Clinical Cancer Research.

[5]  D. Lin,et al.  Evidence for a Dualistic Model of High-grade Serous Carcinoma: BRCA Mutation Status, Histology, and Tubal Intraepithelial Carcinoma , 2015, The American journal of surgical pathology.

[6]  C. Høgdall,et al.  Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology--a prospective comparative study. , 2014, Gynecologic oncology.

[7]  Gregory A. Wyant,et al.  Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. , 2013, Cancer cell.

[8]  Ling-Zhi Wang,et al.  Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer , 2013, EMBO molecular medicine.

[9]  F. Penault-Llorca,et al.  Early Telomere Shortening and Genomic Instability in Tubo-Ovarian Preneoplastic Lesions , 2013, Clinical Cancer Research.

[10]  R. Berkowitz,et al.  Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. , 2013, Gynecologic oncology.

[11]  J. George,et al.  BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[13]  H. Johnsen,et al.  Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers , 2011, PloS one.

[14]  M. Parmar,et al.  Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG) , 2010, International Journal of Gynecologic Cancer.

[15]  I. Shih,et al.  Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin? , 2010, The American journal of surgical pathology.

[16]  G. Kenter,et al.  Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. , 2010, The New England journal of medicine.

[17]  R. Bentley,et al.  Primary peritoneal and ovarian cancers: an epidemiological comparative analysis , 2010, Cancer Causes & Control.

[18]  David Allard,et al.  Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.

[19]  K. Byth,et al.  ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy , 2008, Clinical Cancer Research.

[20]  R. Tothill,et al.  Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome , 2008, Clinical Cancer Research.

[21]  Shelley Tworoger,et al.  A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. , 2008, Gynecologic oncology.

[22]  D. Gertig,et al.  Serous ovarian, fallopian tube and primary peritoneal cancers: A comparative epidemiological analysis , 2007, International journal of cancer.

[23]  R. Berkowitz,et al.  Intraepithelial Carcinoma of the Fimbria and Pelvic Serous Carcinoma: Evidence for a Causal Relationship , 2007, The American journal of surgical pathology.

[24]  J. Garber,et al.  A candidate precursor to serous carcinoma that originates in the distal fallopian tube , 2007 .

[25]  Christopher P Crum,et al.  The Tubal Fimbria Is a Preferred Site for Early Adenocarcinoma in Women With Familial Ovarian Cancer Syndrome , 2006, The American journal of surgical pathology.

[26]  Rochelle L. Garcia,et al.  Pathologic findings in prophylactic oophorectomy specimens in high-risk women. , 2002, Gynecologic oncology.

[27]  Susan L Neuhausen,et al.  Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.

[28]  I. Bukovsky,et al.  Primary peritoneal serous papillary carcinoma: A new epidemiologic trend? A matched-case comparison with ovarian serous papillary cancer , 2001, International Journal of Gynecologic Cancer.

[29]  M. Piver,et al.  Epidemiologic Differences Between Women With Extraovarian Primary Peritoneal Carcinoma and Women With Epithelial Ovarian Cancer , 1998, Obstetrics and gynecology.

[30]  G. Möbius,et al.  Varieties of Serous Surface Papillary Carcinoma of the Peritoneum in Northern Germany: A Thirty‐Year Autopsy Study , 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[31]  K. Tham,et al.  Papillary serous carcinoma of the peritoneum. , 1995, Journal of obstetrics and gynaecology.

[32]  L. Bloss,et al.  Extraovarian peritoneal serous papillary carcinoma: A case‐control retrospective comparison to papillary adenocarcinoma of the ovary , 1994, Gynecologic oncology.

[33]  M. Killackey,et al.  Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma. , 1993, Gynecologic oncology.

[34]  L. Bloss,et al.  Extraovarian peritoneal serous papillary carcinoma: A case‐control retrospective comparison to papillary adenocarcinoma of the ovary , 1993, Gynecologic oncology.

[35]  D. Gershenson,et al.  Papillary serous carcinoma of the peritoneum , 1990, Obstetrics and gynecology.

[36]  M. Friedlander,et al.  Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases , 1989, Cancer.

[37]  S. Mills,et al.  Serous surface papillary carcinoma. A clinicopathologic study of 10 cases and comparison with stage III-IV ovarian serous carcinoma. , 1988, The American journal of surgical pathology.

[38]  J. Tobacman,et al.  INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES , 1982, The Lancet.

[39]  A. Blaustein,et al.  Serous Surface Papillary Carcinoma of the Ovary: A Clinicopathologic Study of 16 Cases , 1982, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[40]  Griffiths Ct.  Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975 .

[41]  H. Osmond-Clarke.  Recurrent Dislocation of the Shoulder , 1947, Lancet.

[42]  M. D. Post,et al.  Are All Pelvic (Nonuterine) Serous Carcinomas of Tubal Origin , 2011 .

[43]  J. Dungan.  A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations , 2009 .

[44]  S. Silverberg.  Toward the development of a universal grading system for ovarian epithelial carcinoma. , 1999, Gynecologic oncology.

[45]  E. Silva,et al.  Ovarian involvement by serous surface papillary carcinoma. , 1994, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[46]  C. Griffiths.  Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. , 1975, National Cancer Institute monograph.

[47]  M. Swerdlow.  Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report. , 1959, American journal of obstetrics and gynecology.